| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 65,294 | 58,409 | 60,825 | 75,651 | | Cost of Revenue | 26,705 | 26,531 | 28,702 | 34,494 | | | Gross Profit | 38,589 | 31,878 | 32,123 | 41,157 | | | Operating Expenses | | Research Development | 8,781 | 9,188 | 10,227 | 11,496 | | Selling General and Administrative | 16,088 | 16,277 | 18,041 | 21,458 | | Non Recurring |
-
| 3,829 | 63 | 4,667 | | Others | 2,665 | 3,010 | 3,165 | 3,168 | | | | Total Operating Expenses |
-
| 32,304 | 31,496 | 40,789 | | | | Operating Income or Loss | 11,055 | (426) | 627 | 368 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 255 | (404) | (233) | 1,667 | | Earnings Before Interest And Taxes | 11,310 | (830) | 394 | 2,035 | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 11,310 | (830) | 394 | 2,035 | | Income Tax Expense | 327 | (274) | 132 | 57 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 10,983 | (556) | 262 | 1,978 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 10,983 | (556) | 262 | 1,978 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $10,983 | ($556) | $262 | $1,978 |
|
1.48% Nasdaq 
Income Statement
